Patents by Inventor Erugu Balaiah

Erugu Balaiah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing pitolisant hydrochloride and solid-state forms thereof
    Patent number: 11945788
    Abstract: The present disclosure relates to a process for preparing pitolisant hydrochloride of Formula-(I) and solid-state forms thereof.
    Type: Grant
    Filed: February 24, 2023
    Date of Patent: April 2, 2024
    Assignee: Nuray Chemicals Private Limited
    Inventors: Ramasamy Venkatragavan, Erugu Balaiah, Paramanandam Senthilkumaran, Guttha Jayaprasad, Manniyam Kailasam Selvam, Noti Krishnareddy, Sorakka Pichandi Parthipan, Murugan Arunkumar, Palaniswamy Premkumar, Salamuthu Kaliraj, Shanmugam Arumugam, Singavarapu Ajay Madhukar, Raman Silambarasan, Saminathan Karthick, Kudumudi Jayaraman Parthiban, Ravi Silambarasan
  • PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF
    Publication number: 20230219914
    Abstract: The present disclosure relates to a process for preparing pitolisant hydrochloride of Formula-(I) and solid-state forms thereof.
    Type: Application
    Filed: February 24, 2023
    Publication date: July 13, 2023
    Applicant: Nuray Chemicals Private Limiited
    Inventors: Ramasamy VENKATRAGAVAN, Erugu BALAIAH, Paramanandam SENTHILKUMARAN, Guttha JAYAPRASAD, Manniyam Kailasam SELVAM, Noti KRISHNAREDDY, Sorakka Pichandi PARTHIPAN, Murugan ARUNKUMAR, Palaniswamy PREMKUMAR, Salamuthu KALIRAJ, Shanmugam ARUMUGAM, Singavarapu Ajay MADHUKAR, Raman SILAMBARASAN, Saminathan KARTHICK, Kudumudi Jayaraman PARTHIBAN, Ravi SILAMBARASAN
  • DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20230149365
    Abstract: The disclosure relates to a novel dosage form comprising hard gelatin or HPMC capsule having granule composition, spray dried or evaporated composition comprising tafamidis or its pharmaceutically acceptable salt particularly tafamidis meglumine or solid-state forms or polymorphic forms of tafamidis particularly tafamidis free acid fumaric acid cocrystal and tablet comprising tafamidis or its pharmaceutically acceptable salt particularly tafamidis meglumine or solid-state forms or polymorphic forms of tafamidis particularly tafamidis free acid fumaric acid cocrystal that would not form a rigid gel upon contacting with water or buffer solution in dissolution specifically pH 6.8 phosphate buffer and that composition is indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.
    Type: Application
    Filed: July 13, 2022
    Publication date: May 18, 2023
    Applicant: Nuray Chemicals Private Limited
    Inventors: Muthusamy SHANMUGAM, Ramasamy VENKATRAGAVAN, Singavarapu Ajay MADHUKAR, Erugu BALAIAH, Palanisamy SIVAKUMAR, Thirunavukkarasu SAKTHIKUMAR
  • Process for preparing pitolisant hydrochloride and solid-state forms thereof
    Patent number: 11623920
    Abstract: The present disclosure relates to a process for preparing pitolisant hydrochloride of Formula-(I) and solid-state forms thereof.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: April 11, 2023
    Assignee: Nuray Chemicals Private Limited
    Inventors: Ramasamy Venkatragavan, Erugu Balaiah, Paramanandam Senthilkumaran, Guttha Jayaprasad, Manniyam Kailasam Selvam, Noti Krishnareddy, Sorakka Pichandi Parthipan, Murugan Arunkumar, Palaniswamy Premkumar, Salamuthu Kaliraj, Shanmugam Arumugam, Singavarapu Ajay Madhukar, Raman Silambarasan, Saminathan Karthick, Kudumudi Jayaraman Parthiban, Ravi Silambarasan
  • PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF
    Publication number: 20220402886
    Abstract: The present disclosure relates to a process for preparing pitolisant hydrochloride of Formula-(I) and solid-state forms thereof.
    Type: Application
    Filed: May 24, 2022
    Publication date: December 22, 2022
    Applicant: Nuray Chemicals Private Lmiited
    Inventors: Ramasamy VENKATRAGAVAN, Erugu BALAIAH, Paramanandam SENTHILKUMARAN, Guttha JAYAPRASAD, Manniyam Kailasam SELVAM, Noti KRISHNAREDDY, Sorakka Pichandi PARTHIPAN, Murugan ARUNKUMAR, Palaniswamy PREMKUMAR, Salamuthu KALIRAJ, Shanmugam ARUMUGAM, Singavarapu Ajay MADHUKAR, Raman SILAMBARASAN, Saminathan KARTHICK, Kudumudi Jayaraman PARTHIBAN, Ravi SILAMBARASAN
  • Dosage forms of tafamidis and its pharmaceutically acceptable salt thereof
    Patent number: 11523993
    Abstract: The disclosure relates to a novel dosage form comprising hard gelatin capsule having granule composition, spray dried or evaporated composition containing tafamidis or its pharmaceutically acceptable salt particularly tafamidis meglumine and tablet comprising tafamidis or its pharmaceutically acceptable salt particularly tafamidis meglumine that would not form a rigid gel upon contacting with water or buffer solution in dissolution specifically pH 6.8 phosphate buffer and that composition is indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: December 13, 2022
    Assignee: Nuray Chemicals Private Limited
    Inventors: Muthusamy Shanmugam, Ramasamy Venkatragavan, Singavarapu Ajay Madhukar, Erugu Balaiah, Palanisamy Sivakumar, Thirunavukkarasu Sakthikumar